Literature DB >> 11205145

Insulin-like growth factor-1 (IGF-1): a neuroprotective trophic factor acting via the Akt kinase pathway.

W H Zheng1, S Kar, S Doré, R Quirion.   

Abstract

Insulin-like growth factor-I (IGF-I) is a pleiotropic polypeptide with a wide range of actions in both central and peripheral nervous sytems. Over the past few years, we studied the trophic as well as neuromodulatory roles of IGF-I in the brain. Accumulated evidence indicates that IGF-I, apart from regulating growth and development, protects neurons against cell death induced by amyloidogenic derivatives, glucose or serum deprivation via the activation of intracellular pathways implicating phosphatidylinositide 3/Akt kinase, winged-helix family of transcription factor FKHRL1 phosphorylation or production of free radicals. The effects of IGF-I on neuroprotection, glucose metabolism and activity-dependent plasticity suggest the potential usefulness of this growth factor or related mimetics in the treatment of Alzheimer's disease and other neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11205145     DOI: 10.1007/978-3-7091-6301-6_17

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  41 in total

Review 1.  Forkhead family transcription factor FoxO and neural differentiation.

Authors:  Qiang Wen; Haitao Wang; Peter J Little; Remi Quirion; Wenhua Zheng
Journal:  Neurogenetics       Date:  2012-03-28       Impact factor: 2.660

2.  PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis.

Authors:  Ravi S Akundi; Lianteng Zhi; Hansruedi Büeler
Journal:  Neurobiol Dis       Date:  2011-09-16       Impact factor: 5.996

3.  Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice.

Authors:  Rose-Marie Bluthé; Keith W Kelley; Robert Dantzer
Journal:  Brain Behav Immun       Date:  2006-01       Impact factor: 7.217

4.  Effect of transgenic human insulin-like growth factor-1 on spinal motor neurons following peripheral nerve injury.

Authors:  Jiaxiang Gu; Hongjun Liu; Naichen Zhang; Heng Tian; Junbo Pan; Wenzhong Zhang; Jingcheng Wang
Journal:  Exp Ther Med       Date:  2015-05-05       Impact factor: 2.447

5.  Insulin-like growth factor-I stimulates histone H3 and H4 acetylation in the brain in vivo.

Authors:  Liou Y Sun; A Joseph D'Ercole
Journal:  Endocrinology       Date:  2006-08-24       Impact factor: 4.736

6.  The role of Akt/FoxO3a in the protective effect of venlafaxine against corticosterone-induced cell death in PC12 cells.

Authors:  Haitao Wang; Xuanhe Zhou; Jianchu Huang; Nan Mu; Zeli Guo; Qiang Wen; Rikang Wang; Shaorui Chen; Zhong-Ping Feng; Wenhua Zheng
Journal:  Psychopharmacology (Berl)       Date:  2013-03-15       Impact factor: 4.530

7.  The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.

Authors:  Daniela F Quail; Robert L Bowman; Leila Akkari; Marsha L Quick; Alberto J Schuhmacher; Jason T Huse; Eric C Holland; James C Sutton; Johanna A Joyce
Journal:  Science       Date:  2016-05-20       Impact factor: 47.728

Review 8.  Insulin resistance and Alzheimer's disease.

Authors:  Suzanne M de la Monte
Journal:  BMB Rep       Date:  2009-08-31       Impact factor: 4.778

Review 9.  The insulin-like growth factor (IGF) receptor type 1 (IGF1R) as an essential component of the signalling network regulating neurogenesis.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2009-08-29       Impact factor: 5.590

Review 10.  Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach.

Authors:  Rongshi Li; Alan Pourpak; Stephan W Morris
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.